244 related articles for article (PubMed ID: 32875601)
1. Therapeutic plasma exchange in a critically ill Covid-19 patient.
Altmayer V; Saheb S; Rohaut B; Marois C; Cao A; Gallo A; Le Guennec L; Weiss N; Demeret S
J Clin Apher; 2021 Feb; 36(1):179-182. PubMed ID: 32875601
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
[TBL] [Abstract][Full Text] [Related]
3. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.
Faqihi F; Alharthy A; Alshaya R; Papanikolaou J; Kutsogiannis DJ; Brindley PG; Karakitsos D
BMC Cardiovasc Disord; 2020 Aug; 20(1):389. PubMed ID: 32842957
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.
Gluck WL; Callahan SP; Brevetta RA; Stenbit AE; Smith WM; Martin JC; Blenda AV; Arce S; Edenfield WJ
Respir Med; 2020 Dec; 175():106188. PubMed ID: 33190086
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma exchange therapy support for critical COVID-19: A case report.
Hua T; Li M; Li X
Ther Apher Dial; 2021 Aug; 25(4):533-535. PubMed ID: 32940386
[No Abstract] [Full Text] [Related]
6. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study.
Faqihi F; Alharthy A; Alodat M; Kutsogiannis DJ; Brindley PG; Karakitsos D
J Crit Care; 2020 Dec; 60():328-333. PubMed ID: 32763058
[TBL] [Abstract][Full Text] [Related]
7. Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.
Shadvar K; Tagizadiyeh A; Gamari AA; Soleimanpour H; Mahmoodpoor A
Blood Purif; 2021; 50(3):405-407. PubMed ID: 33171470
[No Abstract] [Full Text] [Related]
8. Therapeutic plasma exchange in adults with severe COVID-19 infection.
Khamis F; Al-Zakwani I; Al Hashmi S; Al Dowaiki S; Al Bahrani M; Pandak N; Al Khalili H; Memish Z
Int J Infect Dis; 2020 Oct; 99():214-218. PubMed ID: 32585284
[TBL] [Abstract][Full Text] [Related]
9. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.
Beraud M; Hashami SA; Lozano M; Bah A; Keith P
Transfus Apher Sci; 2022 Aug; 61(4):103433. PubMed ID: 35341691
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China.
Xiang H; Song B; Zhang Y; Zhang J; Xiong J
Aging (Albany NY); 2021 Apr; 13(7):9243-9252. PubMed ID: 33811755
[TBL] [Abstract][Full Text] [Related]
11. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
12. Cytokine release syndrome in severe COVID-19.
Moore JB; June CH
Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
[No Abstract] [Full Text] [Related]
13. Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.
Ramírez-Guerrero G; Torres Cifuentes V; Baghetti Hernández R; Villagrán Cortés F; Rojas Doll S; Oliva Alarcón R; Lucero Córdova C; Flores Fernandez P; Garay Coloma O
Blood Purif; 2021; 50(4-5):575-577. PubMed ID: 33264786
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience.
Bouayed MZ; Laaribi I; Benaini I; Yeznasni A; Berrajaa S; Oujidi Y; Bkiyar H; Abda N; Housni B
BMC Infect Dis; 2023 Nov; 23(1):829. PubMed ID: 38007416
[TBL] [Abstract][Full Text] [Related]
15. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
Esmaeili Vardanjani A; Ronco C; Rafiei H; Golitaleb M; Pishvaei MH; Mohammadi M
Blood Purif; 2021; 50(2):257-260. PubMed ID: 32594085
[TBL] [Abstract][Full Text] [Related]
16. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
Wang Q; Hu Z
Int J Infect Dis; 2020 Jul; 96():618-620. PubMed ID: 32470601
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Therapeutic Plasma Exchange in Severe Acute Respiratory Distress Syndrome in COVID-19 Patients from the Western Part of Romania.
Porosnicu TM; Gindac C; Popovici S; Marinescu A; Jipa D; Lazaroiu V; Sandesc D; Oancea C; Folescu R; Zamfir AS; Zamfir CL; Nussbaum LA; Sirbu IO
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556909
[TBL] [Abstract][Full Text] [Related]
18. The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19.
Guo J; Xia H; Wang S; Yu L; Zhang H; Chen J; Shi D; Chen Y; Zhang Y; Xu K; Xu X; Sheng J; Qiu Y; Li L
Front Immunol; 2020; 11():586073. PubMed ID: 33424838
[TBL] [Abstract][Full Text] [Related]
19. The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.
Novacescu AN; Duma G; Sandesc D; Sorescu T; Licker M
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013555
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
